<qa>  What is the name of the three Phase 3 Janssen-sponsored studies?- All patients enrolled in three Phase 3 Janssen-sponsored C0168T37, C0168T46, C0168T72 infliximab clinical studies in ulcerative colitis that require long-term safety follow-up 